IOL Chemicals and Pharmaceuticals Limited (IOLCP.BO)
INR 60.95
(1.96%)
INR 60.95
(1.96%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.34 Billion INR | -3.39% |
| 2022 | 1.39 Billion INR | -17.02% |
| 2021 | 1.67 Billion INR | -62.28% |
| 2020 | 4.44 Billion INR | 23.05% |
| 2019 | 3.61 Billion INR | 52.64% |
| 2018 | 2.36 Billion INR | 754.51% |
| 2017 | 277 Million INR | 493.15% |
| 2016 | 46.7 Million INR | 111.67% |
| 2015 | -400.25 Million INR | 39.95% |
| 2014 | -666.5 Million INR | -2120.08% |
| 2013 | 32.99 Million INR | 107.7% |
| 2012 | 15.88 Million INR | -66.58% |
| 2011 | 47.53 Million INR | -23.08% |
| 2010 | 61.79 Million INR | -38.31% |
| 2009 | 100.15 Million INR | -21.1% |
| 2008 | 126.94 Million INR | 2.68% |
| 2007 | 123.63 Million INR | 63.74% |
| 2006 | 75.5 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 299.7 Million INR | 8.51% |
| 2023 FY | 1.34 Billion INR | -3.39% |
| 2023 Q4 | 276.2 Million INR | 19.67% |
| 2023 Q3 | 230.8 Million INR | -39.05% |
| 2023 Q2 | 378.7 Million INR | -17.42% |
| 2023 Q1 | 458.6 Million INR | -29.2% |
| 2022 Q4 | 647.7 Million INR | 172.37% |
| 2022 Q2 | 159.1 Million INR | -54.11% |
| 2022 Q1 | 346.7 Million INR | 16.5% |
| 2022 FY | 1.39 Billion INR | -17.02% |
| 2022 Q3 | 237.8 Million INR | 49.47% |
| 2021 Q1 | 670 Million INR | -10.96% |
| 2021 Q3 | 400.7 Million INR | 29.93% |
| 2021 FY | 1.67 Billion INR | -62.28% |
| 2021 Q2 | 308.4 Million INR | -53.97% |
| 2021 Q4 | 297.6 Million INR | -25.73% |
| 2020 Q1 | 1.27 Billion INR | 41.3% |
| 2020 Q4 | 752.5 Million INR | -34.46% |
| 2020 Q2 | 1.26 Billion INR | -0.45% |
| 2020 FY | 4.44 Billion INR | 23.05% |
| 2020 Q3 | 1.14 Billion INR | -9.57% |
| 2019 Q3 | 980.1 Million INR | 11.76% |
| 2019 Q1 | 853.2 Million INR | -16.06% |
| 2019 FY | 3.61 Billion INR | 52.64% |
| 2019 Q4 | 902.6 Million INR | -7.91% |
| 2019 Q2 | 877 Million INR | 2.79% |
| 2018 Q3 | 822.4 Million INR | 114.17% |
| 2018 Q2 | 384 Million INR | 166.48% |
| 2018 Q1 | 144.1 Million INR | 25.41% |
| 2018 FY | 2.36 Billion INR | 754.51% |
| 2018 Q4 | 1.01 Billion INR | 23.6% |
| 2017 Q3 | 88 Million INR | 98.65% |
| 2017 FY | 277 Million INR | 493.15% |
| 2017 Q4 | 114.9 Million INR | 30.57% |
| 2017 Q1 | 29.8 Million INR | 49.0% |
| 2017 Q2 | 44.3 Million INR | 48.66% |
| 2016 FY | 46.7 Million INR | 111.67% |
| 2016 Q4 | 20 Million INR | 98.02% |
| 2016 Q3 | 10.1 Million INR | 6.32% |
| 2016 Q2 | 9.5 Million INR | 33.8% |
| 2016 Q1 | 7.1 Million INR | -36.99% |
| 2015 Q2 | -129.3 Million INR | 27.93% |
| 2015 Q4 | 11.26 Million INR | 118.12% |
| 2015 FY | -400.25 Million INR | 39.95% |
| 2015 Q1 | -179.41 Million INR | 36.05% |
| 2015 Q3 | -62.2 Million INR | 51.89% |
| 2014 FY | -666.5 Million INR | -2120.08% |
| 2014 Q4 | -280.55 Million INR | 6.77% |
| 2014 Q3 | -300.93 Million INR | -208.57% |
| 2014 Q2 | -97.52 Million INR | -879.46% |
| 2014 Q1 | 12.51 Million INR | 54.41% |
| 2013 Q4 | 8.1 Million INR | 37.48% |
| 2013 FY | 32.99 Million INR | 107.7% |
| 2013 Q1 | 8.24 Million INR | 1128.09% |
| 2013 Q2 | 10.74 Million INR | 30.29% |
| 2013 Q3 | 5.89 Million INR | -45.16% |
| 2012 Q2 | 4.81 Million INR | -30.08% |
| 2012 Q3 | 3.51 Million INR | -26.98% |
| 2012 Q4 | 671.69 Thousand INR | -80.89% |
| 2012 FY | 15.88 Million INR | -66.58% |
| 2012 Q1 | 6.88 Million INR | 0.0% |
| 2011 FY | 47.53 Million INR | -23.08% |
| 2010 FY | 61.79 Million INR | -38.31% |
| 2009 FY | 100.15 Million INR | -21.1% |
| 2008 FY | 126.94 Million INR | 2.68% |
| 2007 FY | 123.63 Million INR | 63.74% |
| 2006 FY | 75.5 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 78.171% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 95.763% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 71.452% |
| Granules India Limited | 4.05 Billion INR | 66.833% |
| Indoco Remedies Limited | 984.6 Million INR | -36.532% |
| Achyut Healthcare Limited | 5.73 Million INR | -23352.547% |
| Ajanta Pharma Limited | 8.16 Billion INR | 83.529% |
| Alkem Laboratories Limited | 17.95 Billion INR | 92.514% |
| Alpa Laboratories Limited | 167.76 Million INR | -701.299% |
| Brooks Laboratories Limited | -195.91 Million INR | 786.151% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 16.767% |
| Bajaj HealthCare Limited | -837.93 Million INR | 260.431% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -78.161% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 97.586% |
| Eris Lifesciences Limited | 3.91 Billion INR | 65.705% |
| FDC Limited | 3.05 Billion INR | 55.957% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 108.952% |
| Gufic Biosciences Limited | 861.35 Million INR | -56.068% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 68.066% |
| Ipca Laboratories Limited | 5.47 Billion INR | 75.44% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -498.451% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 781.403% |
| Lasa Supergenerics Limited | -217.3 Million INR | 718.621% |
| Laurus Labs Limited | 1.6 Billion INR | 16.269% |
| Lupin Limited | 19.14 Billion INR | 92.978% |
| Mankind Pharma Limited | 19.12 Billion INR | 92.972% |
| Medicamen Biotech Limited | 109.31 Million INR | -1129.805% |
| Medico Remedies Limited | 82.9 Million INR | -1521.416% |
| Megasoft Limited | -127.46 Million INR | 1154.634% |
| NATCO Pharma Limited | 13.88 Billion INR | 90.317% |
| Piramal Pharma Limited | 178.2 Million INR | -654.377% |
| RPG Life Sciences Limited | 876.6 Million INR | -53.354% |
| Sigachi Industries Limited | 571.8 Million INR | -135.099% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 98.596% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 55.232% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -431.046% |
| Unichem Laboratories Limited | -704.74 Million INR | 290.75% |
| Wanbury Limited | 559.56 Million INR | -140.241% |
| Windlas Biotech Limited | 581.87 Million INR | -131.031% |
| ZIM Laboratories Limited | 172.46 Million INR | -679.467% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 96.517% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 134.717% |
| Divi's Laboratories Limited | 16 Billion INR | 91.598% |
| Hester Biosciences Limited | 188.89 Million INR | -611.684% |
| Procter & Gamble Health Limited | 2 Billion INR | 33.113% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -198.915% |
| Bal Pharma Limited | 73.92 Million INR | -1718.538% |
| Strides Pharma Science Limited | -706.14 Million INR | 290.373% |
| Venus Remedies Limited | 284.9 Million INR | -371.837% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 38.023% |
| Nectar Lifesciences Limited | 49.95 Million INR | -2591.291% |
| Shilpa Medicare Limited | 318.74 Million INR | -321.752% |
| Aarti Drugs Limited | 1.71 Billion INR | 21.578% |
| Suven Life Sciences Limited | -1.05 Billion INR | 227.936% |
| Ind-Swift Limited | 142.31 Million INR | -844.608% |
| Valiant Laboratories Limited | 3.19 Million INR | -41961.952% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 75.674% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 123.693% |
| Themis Medicare Limited | 435.23 Million INR | -208.865% |
| Hikal Limited | 696.02 Million INR | -93.141% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 91.884% |
| Sequent Scientific Limited | -358.69 Million INR | 474.78% |
| Novartis India Limited | 851.9 Million INR | -57.8% |
| Wockhardt Limited | -4.63 Billion INR | 129.035% |
| Jubilant Pharmova Limited | 771 Million INR | -74.358% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -18855.161% |
| Neuland Laboratories Limited | 3 Billion INR | 55.202% |
| Morepen Laboratories Limited | 961.59 Million INR | -39.798% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -820.665% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 1581.861% |